| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1365-2125.2010.03650.X |
| P8608 | Fatcat ID | release_d64dedksajfsrgqcplvkicgvzq |
| P932 | PMC publication ID | 2883763 |
| P698 | PubMed publication ID | 20565462 |
| P5875 | ResearchGate publication ID | 44689982 |
| P50 | author | Wouter Meersseman | Q92550163 |
| Philippe Meersseman | Q114448782 | ||
| P2093 | author name string | Isabel Spriet | |
| Philippe Meersseman | |||
| Jan de Hoon | |||
| Ludo Willems | |||
| P2860 | cites work | Pharmacokinetics, metabolism and bioavailability of the triazole antifungal agent voriconazole in relation to CYP2C19 genotype | Q33608028 |
| Factors influencing the magnitude and clinical significance of drug interactions between azole antifungals and select immunosuppressants. | Q36662912 | ||
| Antifungal therapeutic drug monitoring: established and emerging indications | Q37310029 | ||
| Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents | Q37441245 | ||
| Phenytoin-induced reduction of voriconazole serum concentration is not compensated by doubling the dosage | Q42590878 | ||
| Coadministration of voriconazole and phenytoin: pharmacokinetic interaction, safety, and toleration | Q42760098 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | voriconazole | Q412236 |
| P304 | page(s) | 701-702 | |
| P577 | publication date | 2010-06-01 | |
| P1433 | published in | British Journal of Clinical Pharmacology | Q176044 |
| P1476 | title | Increasing the dose of voriconazole compensates for enzyme induction by phenytoin | |
| P478 | volume | 69 |
Search more.